(NYSE: COR) Cencora's forecast annual revenue growth rate of 5.09% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 6.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.78%.
Cencora's revenue in 2025 is $316,654,371,000.On average, 5 Wall Street analysts forecast COR's revenue for 2025 to be $62,246,959,821,696, with the lowest COR revenue forecast at $62,100,015,898,129, and the highest COR revenue forecast at $62,461,191,002,644. On average, 6 Wall Street analysts forecast COR's revenue for 2026 to be $66,603,159,664,507, with the lowest COR revenue forecast at $65,870,048,845,326, and the highest COR revenue forecast at $67,675,364,448,580.
In 2027, COR is forecast to generate $71,318,508,006,343 in revenue, with the lowest revenue forecast at $69,716,489,065,426 and the highest revenue forecast at $72,602,098,231,826.